Jade Biosciences, Inc. Property, Plant and Equipment, Gross
Jade Biosciences, Inc. (JBIO) had Property, Plant and Equipment, Gross of $40.00 thousand as of 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2021-08-16
- 2021-06-30: Property, Plant and Equipment, Gross $40.00K.
- 2020-12-31: Property, Plant and Equipment, Gross $40.00K.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2021-06-30 | $40.00K 10-Q · filed 2021-08-16 |
| 2020-12-31 | $40.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |